谢芳, 蒋欣廷, 张睿, 华杨, 梁俐. 4种预后预测评分系统在脊柱转移瘤预后预测中的一致性与准确性[J]. 实用临床医药杂志, 2023, 27(21): 52-58. DOI: 10.7619/jcmp.20232326
引用本文: 谢芳, 蒋欣廷, 张睿, 华杨, 梁俐. 4种预后预测评分系统在脊柱转移瘤预后预测中的一致性与准确性[J]. 实用临床医药杂志, 2023, 27(21): 52-58. DOI: 10.7619/jcmp.20232326
XIE Fang, JIANG Xinting, ZHANG Rui, HUA Yang, LIANG Li. Consistency and accuracy of four prognostic scoring systems in predicting prognosis of patients with spinal metastasis[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 52-58. DOI: 10.7619/jcmp.20232326
Citation: XIE Fang, JIANG Xinting, ZHANG Rui, HUA Yang, LIANG Li. Consistency and accuracy of four prognostic scoring systems in predicting prognosis of patients with spinal metastasis[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 52-58. DOI: 10.7619/jcmp.20232326

4种预后预测评分系统在脊柱转移瘤预后预测中的一致性与准确性

Consistency and accuracy of four prognostic scoring systems in predicting prognosis of patients with spinal metastasis

  • 摘要:
    目的 探讨Tomita评分、修订Tokuhashi评分、Rades评分和Oswestry脊柱风险指数(OSRI)预测脊柱转移瘤患者预后的一致性和准确性。
    方法 收集2010年1月—2020年12月宜宾市2所综合性医院收治的127例脊柱转移瘤住院患者的病历资料,随访截止日期为2022年6月30日。采用Kaplan-Meier法绘制生存曲线, Log-rank χ2检验和Cox回归模型分析影响预后的因素, Kappa值评估预测生存时间和实际生存时间的一致性,曲线下面积(AUC)评估各评分系统预测脊柱转移瘤患者生存时间的准确性。
    结果 患者生存时间为10(6, 14)个月,随访期内病死率为76.38%, 6、12个月生存率分别为69.3%、27.6%。Tomita评分、修订Tokuhashi评分、Rades评分和OSRI预测患者生存时间的AUC分别为0.968、0.957、0.930和0.798, 最佳截断值分别为4.5、10.5、36.5和2.5。Cox回归分析显示, Tomita评分、修订Tokuhashi评分、Rades评分和是否有内脏转移这4个因素是脊柱转移瘤患者预后的预测因子; 修订Tokuhashi评分≤8分和9~11分的风险比(HR)分别为9.328和6.417, Tomita评分2~3分、4~5分和6~7分的HR分别为0.183、0.197和0.398, Rades评分≤30分和31~35分的HR分别为2.898和2.166, 内脏转移可切除和不可切除的HR分别为1.517和4.116。修订Tokuhashi评分预测6、12个月生存率的Kappa值>0.40, 而Tomita评分、Rades评分和OSRI预测的Kappa值均 < 0.40。修订Tokuhashi评分预测患者6个月生存率的准确性最高(AUC=0.863), Tomita评分准确性一般(AUC=0.717), Rades评分和OSRI准确性较差(AUC < 0.70)。
    结论 脊柱转移瘤患者预后差,其预后与多种因素有关。修订Tokuhashi评分预测患者预后的准确性和一致性相对较高。

     

    Abstract:
    Objective To explore the consistency and accuracy of Tomita score, revised Tokuhashi score, Rades score and Oswestry spinal risk index (OSRI) in predicting the prognosis of patients with spinal metastasis.
    Methods The medical records of 127 hospitalized patients with spinal metastasis admitted to two comprehensive hospitals in Yibin City from January 2010 to December 2020 were collected, and the deadline for follow-up was June 30, 2022. The Kaplan-Meier method was used to draw the survival curve, the Log-rank Chi-square test and Cox regression analysis were used to analyze the factors affecting prognosis, the Kappa value was used to evaluate the consistency between predicted and actual survival time, and area under the curve (AUC) was used to evaluate the accuracy of four scoring systems in predicting survival time of patients with spinal metastases.
    Results The patient′s survival time was 10 (6, 14) months, with a mortality rate of 76.38% during the follow-up period, and the 6-month and 12-month survival rates were 69.3% and 27.6% respectively. The AUC values of Tomita score, revised Tokuhashi score, Rades score and OSRI in predicting patient′s survival time were 0.968, 0.957, 0.930 and 0.798 respectively, with the optimal cut-off values of 4.5, 10.5, 36.5 and 2.5. Cox regression analysis showed that the four factors such as Tomita score, revised Tokuhashi score, Rades score and presence or absence of visceral metastasis were the predictive factors for the prognosis of patients with spinal metastasis; the hazard ratio (HR) values for revised Tokuhashi score ≤ 8 and 9 to 11 were 9.328 and 6.417 respectively, the HR values for Tomita score 2 to 3, 4 to 5 and 6 to 7 were 0.183, 0.197 and 0.398 respectively, the HR values for Rades score ≤ 30 and 31 to 35 were 2.898 and 2.166 respectively, and the HR for resectable and non-resectable visceral metastases were 1.517 and 4.116, respectively. The revised Tokuhashi score predicted a Kappa value >0.40 for 6-month and 12-month survival rates, while the Tomita score, Rades score and OSRI predicted a Kappa value < 0.40. The revised Tokuhashi score had the highest accuracy in predicting patient′s 6-month survival (AUC=0.863), the Tomita score had average accuracy (AUC=0.717), and the Rades score and OSRI had poor accuracy (AUC < 0.70).
    Conclusion The prognosis of patients with spinal metastasis is poor, and the prognosis is related to multiple factors. The revised Tokuhashi score has relatively high accuracy and consistency in predicting prognosis of patients.

     

/

返回文章
返回